{"pmid":32445403,"title":"SARS-CoV-2 infection-induced immune responses: friends or foes?","text":["SARS-CoV-2 infection-induced immune responses: friends or foes?","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging coronavirus that belongs to the beta genus, causing the outbreak of coronavirus disease 19 (COVID-19). SARS-CoV-2 infection can stimulate a pronounced immune response in the host, which embodies in the decrease of lymphocytes and aberrant increase of cytokines in COVID-19 patients. SARS-CoV-2 RNA and proteins interact with various pattern recognition receptors that switch on antiviral immune responses to regulate viral replication and spreading within the host in vivo. However, overactive and impaired immune responses also cause immune damage and subsequent tissue inflammation. This article focuses on the dual roles of immune system during SARS-CoV-2 infection, providing a theoretical basic for identifying therapeutic targets in a situation with an unfavorable immune reaction.","Scand J Immunol","Li, Keying","Hao, Zhenhua","Zhao, Xiaohui","Du, Jiying","Zhou, Yanlin","32445403"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging coronavirus that belongs to the beta genus, causing the outbreak of coronavirus disease 19 (COVID-19). SARS-CoV-2 infection can stimulate a pronounced immune response in the host, which embodies in the decrease of lymphocytes and aberrant increase of cytokines in COVID-19 patients. SARS-CoV-2 RNA and proteins interact with various pattern recognition receptors that switch on antiviral immune responses to regulate viral replication and spreading within the host in vivo. However, overactive and impaired immune responses also cause immune damage and subsequent tissue inflammation. This article focuses on the dual roles of immune system during SARS-CoV-2 infection, providing a theoretical basic for identifying therapeutic targets in a situation with an unfavorable immune reaction."],"journal":"Scand J Immunol","authors":["Li, Keying","Hao, Zhenhua","Zhao, Xiaohui","Du, Jiying","Zhou, Yanlin"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445403","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/sji.12895","keywords":["severe acute respiratory syndrome coronavirus 2 (sars-cov-2)","coronavirus disease 19 (covid-19)","cytokine storm","inflammation"],"locations":["vivo"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667600475751448577,"score":9.490897,"similar":[{"pmid":32299202,"title":"COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs","text":["COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs","In the Wuhan Province of China, in December 2019, the novel coronavirus 2019 (COVID-19) has caused a severe involvement of the lower respiratory tract leading to an acute respiratory syndrome. Subsequently, coronavirus 2 (SARS-CoV-2) provoked a pandemic which is considered a life-threatening disease. The SARS-CoV-2, a family member of betacoronaviruses, possesses single-stranded positive-sense RNA with typical structural proteins, involving the envelope, membrane, nucleocapsid and spike proteins that are responsible for the viral infectivity, and nonstructural proteins. The effectual host immune response including innate and adaptive immunity against SARS-Cov-2 seems crucial to control and resolve the viral infection. However, the severity and outcome of the COVID-19 might be associated with the excessive production of proinflammatory cytokines \"cytokine storm\" leading to an acute respiratory distress syndrome. Regretfully, the exact pathophysiology and treatment, especially for the severe COVID-19, is still uncertain. The results of preliminary studies have shown that immune-modulatory or immune-suppressive treatments such as hydroxychloroquine, interleukin (IL)-6 and IL-1 antagonists, commonly used in rheumatology, might be considered as treatment choices for COVID-19, particularly in severe disease. In this review, to gain better information about appropriate anti-inflammatory treatments, mostly used in rheumatology for COVID-19, we have focused the attention on the structural features of SARS-CoV-2, the host immune response against SARS-CoV-2 and its association with the cytokine storm.","Turk J Med Sci","Tufan, Abdurrahman","Avanoglu Guler, Aslihan","Matucci-Cerinic, Marco","32299202"],"abstract":["In the Wuhan Province of China, in December 2019, the novel coronavirus 2019 (COVID-19) has caused a severe involvement of the lower respiratory tract leading to an acute respiratory syndrome. Subsequently, coronavirus 2 (SARS-CoV-2) provoked a pandemic which is considered a life-threatening disease. The SARS-CoV-2, a family member of betacoronaviruses, possesses single-stranded positive-sense RNA with typical structural proteins, involving the envelope, membrane, nucleocapsid and spike proteins that are responsible for the viral infectivity, and nonstructural proteins. The effectual host immune response including innate and adaptive immunity against SARS-Cov-2 seems crucial to control and resolve the viral infection. However, the severity and outcome of the COVID-19 might be associated with the excessive production of proinflammatory cytokines \"cytokine storm\" leading to an acute respiratory distress syndrome. Regretfully, the exact pathophysiology and treatment, especially for the severe COVID-19, is still uncertain. The results of preliminary studies have shown that immune-modulatory or immune-suppressive treatments such as hydroxychloroquine, interleukin (IL)-6 and IL-1 antagonists, commonly used in rheumatology, might be considered as treatment choices for COVID-19, particularly in severe disease. In this review, to gain better information about appropriate anti-inflammatory treatments, mostly used in rheumatology for COVID-19, we have focused the attention on the structural features of SARS-CoV-2, the host immune response against SARS-CoV-2 and its association with the cytokine storm."],"journal":"Turk J Med Sci","authors":["Tufan, Abdurrahman","Avanoglu Guler, Aslihan","Matucci-Cerinic, Marco"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32299202","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.3906/sag-2004-168","keywords":["covid-19","cytokine storm","inflammation","rheumatology","treatment","antiinflammatory"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Hydroxychloroquine"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138494766940161,"score":234.04854},{"pmid":31981224,"pmcid":"PMC7166547","title":"Coronavirus infections and immune responses.","text":["Coronavirus infections and immune responses.","Coronaviruses (CoVs) are by far the largest group of known positive-sense RNA viruses having an extensive range of natural hosts. In the past few decades, newly evolved Coronaviruses have posed a global threat to public health. The immune response is essential to control and eliminate CoV infections, however, maladjusted immune responses may result in immunopathology and impaired pulmonary gas exchange. Gaining a deeper understanding of the interaction between Coronaviruses and the innate immune systems of the hosts may shed light on the development and persistence of inflammation in the lungs and hopefully can reduce the risk of lung inflammation caused by CoVs. In this review, we provide an update on CoV infections and relevant diseases, particularly the host defense against CoV-induced inflammation of lung tissue, as well as the role of the innate immune system in the pathogenesis and clinical treatment.","J Med Virol","Li, Geng","Fan, Yaohua","Lai, Yanni","Han, Tiantian","Li, Zonghui","Zhou, Peiwen","Pan, Pan","Wang, Wenbiao","Hu, Dingwen","Liu, Xiaohong","Zhang, Qiwei","Wu, Jianguo","31981224"],"abstract":["Coronaviruses (CoVs) are by far the largest group of known positive-sense RNA viruses having an extensive range of natural hosts. In the past few decades, newly evolved Coronaviruses have posed a global threat to public health. The immune response is essential to control and eliminate CoV infections, however, maladjusted immune responses may result in immunopathology and impaired pulmonary gas exchange. Gaining a deeper understanding of the interaction between Coronaviruses and the innate immune systems of the hosts may shed light on the development and persistence of inflammation in the lungs and hopefully can reduce the risk of lung inflammation caused by CoVs. In this review, we provide an update on CoV infections and relevant diseases, particularly the host defense against CoV-induced inflammation of lung tissue, as well as the role of the innate immune system in the pathogenesis and clinical treatment."],"journal":"J Med Virol","authors":["Li, Geng","Fan, Yaohua","Lai, Yanni","Han, Tiantian","Li, Zonghui","Zhou, Peiwen","Pan, Pan","Wang, Wenbiao","Hu, Dingwen","Liu, Xiaohong","Zhang, Qiwei","Wu, Jianguo"],"date":"2020-01-26T11:00:00Z","year":2020,"_id":"31981224","source":"PubMed","week":"20204|Jan 20 - Jan 26","doi":"10.1002/jmv.25685","keywords":["chemokine","coronavirus","cytokines","inflammation","interferon"],"locations":["Coronaviruses","Coronaviruses"],"topics":["Transmission","Mechanism","Treatment"],"weight":1,"_version_":1666138490926006272,"score":223.5318},{"pmid":32502542,"pmcid":"PMC7266583","title":"The immune system and COVID-19: Friend or foe?","text":["The immune system and COVID-19: Friend or foe?","AIM: Coronavirus disease 2019 (COVID-19) is a novel highly contagious infection caused by SARS-CoV-2, which has been became a global public health challenge. The pathogenesis of this virus is not yet clearly understood, but there is evidence of a hyper-inflammatory immune response in critically ill patients, which leads to acute respiratory distress syndrome (ARDS) and multi-organ failure. MATERIAL AND METHODS: A literature review was performed to identify relevant articles on COVID-19 published up to April 30, 2020. The search resulted in 361 total articles. After reviewing the titles and abstracts for inclusion, some irrelevant papers were excluded. Additional relevant articles were identified from a review of citations referenced. KEY FINDINGS: SARS-CoV-2, directly and indirectly, affects the immune system and avoids being eliminated in early stages. On the other hand, the secretion of inflammatory cytokines creates critical conditions that lead to multi-organ failure. SIGNIFICANCE: The immune system which is affected by the virus tries to respond via a cytokine storm and hyperinflammation, which itself leads to further multi-organ damage and even death.","Life Sci","Yazdanpanah, Fereshteh","Hamblin, Michael R","Rezaei, Nima","32502542"],"abstract":["AIM: Coronavirus disease 2019 (COVID-19) is a novel highly contagious infection caused by SARS-CoV-2, which has been became a global public health challenge. The pathogenesis of this virus is not yet clearly understood, but there is evidence of a hyper-inflammatory immune response in critically ill patients, which leads to acute respiratory distress syndrome (ARDS) and multi-organ failure. MATERIAL AND METHODS: A literature review was performed to identify relevant articles on COVID-19 published up to April 30, 2020. The search resulted in 361 total articles. After reviewing the titles and abstracts for inclusion, some irrelevant papers were excluded. Additional relevant articles were identified from a review of citations referenced. KEY FINDINGS: SARS-CoV-2, directly and indirectly, affects the immune system and avoids being eliminated in early stages. On the other hand, the secretion of inflammatory cytokines creates critical conditions that lead to multi-organ failure. SIGNIFICANCE: The immune system which is affected by the virus tries to respond via a cytokine storm and hyperinflammation, which itself leads to further multi-organ damage and even death."],"journal":"Life Sci","authors":["Yazdanpanah, Fereshteh","Hamblin, Michael R","Rezaei, Nima"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32502542","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.lfs.2020.117900","keywords":["acute respiratory distress syndrome","covid-19","cytokine storm","hyperinflammation","immune system"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668890966397812737,"score":221.66602},{"pmid":32471272,"title":"Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?","text":["Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?","In late December 2019, a novel coronavirus (SARS-CoV-2 or CoV-19) appeared in Wuhan, China, causing a global pandemic. SARS-CoV-2 causes mild to severe respiratory tract inflammation, often developing into lung fibrosis with thrombosis in pulmonary small vessels and causing even death. COronaVIrus Disease (COVID-19) patients manifest exacerbated inflammatory and immune responses, cytokine storm, prevalence of pro-inflammatory M1 macrophages and increased levels of resident and circulating immune cells. Men show higher susceptibility to SARS-CoV-2 infection than women, likely due to estrogens production. The protective role of&nbsp;estrogens, as well as an immune-suppressive activity that limits the excessive inflammation, can be mediated by cannabinoid receptor type 2 (CB2). The role of this receptor in modulating inflammation and immune response is well documented in fact in several settings. The stimulation of CB2 receptors is known to limit the release of pro-inflammatory cytokines, shift the macrophage phenotype towards the anti-inflammatory M2 type and enhance the immune-modulating properties of mesenchymal stromal cells. For these reasons, we hypothesize that CB2 receptor can be a therapeutic target in COVID-19 pandemic emergency.","Int J Mol Sci","Rossi, Francesca","Tortora, Chiara","Argenziano, Maura","Di Paola, Alessandra","Punzo, Francesca","32471272"],"abstract":["In late December 2019, a novel coronavirus (SARS-CoV-2 or CoV-19) appeared in Wuhan, China, causing a global pandemic. SARS-CoV-2 causes mild to severe respiratory tract inflammation, often developing into lung fibrosis with thrombosis in pulmonary small vessels and causing even death. COronaVIrus Disease (COVID-19) patients manifest exacerbated inflammatory and immune responses, cytokine storm, prevalence of pro-inflammatory M1 macrophages and increased levels of resident and circulating immune cells. Men show higher susceptibility to SARS-CoV-2 infection than women, likely due to estrogens production. The protective role of&nbsp;estrogens, as well as an immune-suppressive activity that limits the excessive inflammation, can be mediated by cannabinoid receptor type 2 (CB2). The role of this receptor in modulating inflammation and immune response is well documented in fact in several settings. The stimulation of CB2 receptors is known to limit the release of pro-inflammatory cytokines, shift the macrophage phenotype towards the anti-inflammatory M2 type and enhance the immune-modulating properties of mesenchymal stromal cells. For these reasons, we hypothesize that CB2 receptor can be a therapeutic target in COVID-19 pandemic emergency."],"journal":"Int J Mol Sci","authors":["Rossi, Francesca","Tortora, Chiara","Argenziano, Maura","Di Paola, Alessandra","Punzo, Francesca"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32471272","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3390/ijms21113809","keywords":["covid-19","sars-cov-2","cannabinoid receptor type 2","endocannabinoids system","immune response","inflammation","molecular target","therapeutic strategies"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668255193299419136,"score":203.3862},{"pmid":32446778,"title":"The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.","text":["The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.","In 2019-2020 a new coronavirus named SARS-CoV-2 was identified as the causative agent of a several acute respiratory infection named COVID-19, which is causing a worldwide pandemic. There are still many unresolved questions regarding the pathogenesis of this disease and especially the reasons underlying the extremely different clinical course, ranging from asymptomatic forms to severe manifestations, including the Acute Respiratory Distress Syndrome (ARDS). SARS-CoV-2 showed phylogenetic similarities to both SARS-CoV and MERS-CoV viruses, and some of the clinical features are shared between COVID-19 and previously identified beta-coronavirus infections. Available evidence indicate that the so called \"cytokine storm\" an uncontrolled over-production of soluble markers of inflammation which, in turn, sustain an aberrant systemic inflammatory response, is a major responsible for the occurrence of ARDS. Chemokines are low molecular weight proteins with powerful chemoattractant activity which play a role in the immune cell recruitment during inflammation. This review will be aimed at providing an overview of the current knowledge on the involvement of the chemokine/chemokine-receptor system in the cytokine storm related to SARS-CoV-2 infection. Basic and clinical evidences obtained from previous SARS and MERS epidemics and available data from COVID-19 will be taken into account.","Cytokine Growth Factor Rev","Coperchini, Francesca","Chiovato, Luca","Croce, Laura","Magri, Flavia","Rotondi, Mario","32446778"],"abstract":["In 2019-2020 a new coronavirus named SARS-CoV-2 was identified as the causative agent of a several acute respiratory infection named COVID-19, which is causing a worldwide pandemic. There are still many unresolved questions regarding the pathogenesis of this disease and especially the reasons underlying the extremely different clinical course, ranging from asymptomatic forms to severe manifestations, including the Acute Respiratory Distress Syndrome (ARDS). SARS-CoV-2 showed phylogenetic similarities to both SARS-CoV and MERS-CoV viruses, and some of the clinical features are shared between COVID-19 and previously identified beta-coronavirus infections. Available evidence indicate that the so called \"cytokine storm\" an uncontrolled over-production of soluble markers of inflammation which, in turn, sustain an aberrant systemic inflammatory response, is a major responsible for the occurrence of ARDS. Chemokines are low molecular weight proteins with powerful chemoattractant activity which play a role in the immune cell recruitment during inflammation. This review will be aimed at providing an overview of the current knowledge on the involvement of the chemokine/chemokine-receptor system in the cytokine storm related to SARS-CoV-2 infection. Basic and clinical evidences obtained from previous SARS and MERS epidemics and available data from COVID-19 will be taken into account."],"journal":"Cytokine Growth Factor Rev","authors":["Coperchini, Francesca","Chiovato, Luca","Croce, Laura","Magri, Flavia","Rotondi, Mario"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32446778","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.cytogfr.2020.05.003","keywords":["covid-19","cxcl10","cxcl8","chemokines","coronavirus","cytokine storm"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667698385850728449,"score":197.79492}]}